Загрузка...
Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019
Concerning development of medicinal products, children belong to a so-called “special population” for which additional legislation applies: Regulation (EC) No 1901/2006 on medicinal products for paediatric use sets up a system of requirements, rewards and incentives to ensure that medicinal products...
Сохранить в:
| Опубликовано в: : | Clin Transl Allergy |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7325268/ https://ncbi.nlm.nih.gov/pubmed/32612805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-020-00327-w |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|